𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Anti-tumor activity of daunorubicin linked to poly-L-aspartic acid

✍ Scribed by Franco Zunino; Fernando Giuliani; Giuseppina Savi; Teresa Dasdia; Romolo Gambetta

Publisher
John Wiley and Sons
Year
1982
Tongue
French
Weight
566 KB
Volume
30
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Daunorubicin was bound to poly‐l‐aspartic acid via the methylketone side chain of the drug to avoid reaction of the sugar amino group believed to be essential for optimal drug activity. Attachment of the drug to the poly‐amino acid by an ester linkage was achieved by nucleophylic substitution reaction of 14‐bromo‐daunorubicin. Compared with free daunorubicin, the polymeric derivative was less cytotoxic to HeLa cells in vitro, but more effective against all tumor models tested (P388 leukemia, Gross leukemia, MS‐2 sarcoma). The binding to the poly‐peptide markedly reduced drug toxicity but only slightly decreased drug potency. The daunorubicin‐poly‐L‐aspartic acid conjugate demonstrated antitumor activity comparable to that of doxorubicin in leukemia models, but superior to that of doxorubicin in a solid tumor model (MS‐2 sarcoma).

📜 SIMILAR VOLUMES

Anti-tumoral activity of L and D isomers
Anti-tumoral activity of L and D isomers of aspartic acid β-hydroxamate on L5178Y leukemia
✍ Nicole Thomasset; Farid Hamedi-Sangsari; Roselyne Tournaire; Claudine Navarro; S 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 French ⚖ 463 KB

Death before the time of death of untreated controls.-'Increased life s an see "Material and Meth0ds."-~3 times daily at 8-hr inter~aIs.-~Twice daig a: 12-hr interval.-'Once a day.

Inhibition of mTOR signaling by oleanoli
Inhibition of mTOR signaling by oleanolic acid contributes to its anti-tumor activity in osteosarcoma cells
✍ Rongping Zhou; Zhongmin Zhang; Li Zhao; Chunhong Jia; Song Xu; Qiguang Mai; Ming 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 344 KB

## Abstract Oleanolic acid (OA), a pentacyclic triterpenoid exhibits potent anti‐tumor activity against many tumor cell lines. But the mechanisms through which OA inhibits osteosarcoma cells are not known. The mammalian target of rapamycin (mTOR) serves as a central regulator of cell growth, prolif

In vitro and in vivo anti-tumor activity
In vitro and in vivo anti-tumor activity of L-glutamic acid γ-monohydroxamate against L1210 leukemia and B16 melanoma
✍ Jorge Vila; Nicole Thomasset; Claudine Navarro; Jean-François Doré 📂 Article 📅 1990 🏛 John Wiley and Sons 🌐 French ⚖ 655 KB

## Abstract A glutamine analogue, L‐glutamic acid γ‐monohydroxamate (GAH) demonstrated complete cytotoxicity against L1210 cells in culture and marked anti‐tumoral activity __in vivo__ against L1210 leukemia and B16 melanoma. __In vitro__, GAH caused concentration‐dependent inhibition of L1210 cell

Lunasin, with an arginine–glycine–aspart
Lunasin, with an arginine–glycine–aspartic acid motif, causes apoptosis to L1210 leukemia cells by activation of caspase-3
✍ Elvira Gonzalez de Mejia; Wenyi Wang; Vermont P. Dia 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 347 KB

## Abstract Lunasin is a novel chemopreventive peptide featuring a cell adhesion motif composed of arginine–glycine–aspartate (RGD) which has been associated to cytotoxicity to established cell lines. The objectives of this study were to determine the effect of lunasin on the viability of L1210 leu